ArticleFunctional & integrative genomics2026
MICA and CYTH4 as immunological biomarkers of intracranial aneurysm: a study integrating RNA sequencing, single-cell sequencing and Mendelian randomization.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracranial aneurysm (IA) is a common cerebral vascular malformation often leading to subarachnoid hemorrhage (SAH) with high mortality and disability rates. The molecular mechanisms underlying IA occurrence and rupture are poorly understood, highlighting the need for predictive molecular markers. Here, we employed bioinformatics and Mendelian randomization analysis to identify MICA and CYTH4 as molecular markers closely associated with arterial aneurysm rupture, offering new insights for IA prevention and treatment. We integrated five datasets (GSE15629, GSE26969, GSE54083, GSE13353, and GSE122897) to create a research cohort of 34 non-IA and 93 IA samples. Differential gene expression analysis was performed using single-cell sequencing data from IA mice, followed by KEGG enrichment analysis. Mendelian randomization analysis was conducted on two samples to determine the causal relationship between gene expression and IA risk. Receiver operating characteristic (ROC) and decision curve analysis (DCA) curves were constructed. We further conducted GSEA, immune microenvironment analysis, cell trajectory analysis, and intercellular communication research on single-cell data. Molecular biology experiments have confirmed that altered expression of MICA and CYTH4 can effectively regulate the proliferation of endothelial cells and their apoptosis under stress conditions. We identified 297 downregulated and 295 upregulated DEGs between IA and control groups. KEGG enrichment analysis implicated cytokines, NF-κB signaling, and TNF signaling in promoting IA onset, while cAMP signaling may inhibit it. Mendelian randomization analysis revealed MICA and CYTH4 as key genes related to IA prognosis, with CYTH4 as a risk factor, and MICA potentially protective. GSEA and GeneMANIA enrichment analysis indicated roles for CYTH4 and MICA in immune regulation of IA. Single-cell sequencing data linked CYTH4 to neutrophil degranulation during macrophage differentiation, with CellChat showing correlation between CYTH4 and CCL signaling. This study highlights MICA and CYTH4 as significant biomarkers for IA progression, particularly CYTH4's role in immune inflammatory response and prognosis. These findings contribute to understanding IA pathogenesis and advancing its diagnosis and treatment.
Indexed as
Identifiers
42154081What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.